Gemini Bioproducts, LLC has entered a distribution agreement with Nordmark Biochemicals, a division of Nordmark Arzneimittel GmbH & Co. KG. Launching this week, customers in the U.S. can now purchase Nordmark’s line of collagenase and neutral protease products directly from Gemini.

Nordmark, one of the world’s largest manufacturers of pharmaceutical collagenase, provides translational enzymes – research and GMP Grade collagenase and neutral protease products – to help simplify the path from research to clinic. Nordmark offers products for cell isolation applications, including the highly purified, animal-free Collagenase NB grades.

Brendan Lucey, Gemini Bio-Products VP of Business Development, stated, “I am extremely excited to add Nordmark’s line of collagenases to Gemini Bioproducts’ portfolio. We continue our focus on supporting breakthroughs in the cell therapy field with reagents that allow for an easy transition from R&D to manufacturing.”

Detlev Baumeister, Nordmark’s CFO and Managing Director, added, “We are delighted and looking forward to working closely with Gemini Bio-Products, which offers us the opportunity to market our products on a very valuable platform. Sharing the same vision and spirit, this partnership combines Nordmark’s excellent manufacturing expertise and outstanding product performance with Gemini’s first- rate sales network and potent marketing abilities in the US.”